Proteasomal activity-based probes mark protein homeostasis in muscles by Raz, V. et al.
Proteasomal activity-based probes mark protein
homeostasis in muscles
Vered Raz1*, Yotam Raz1, Guillem Paniagua-Soriano2, Jacomina Cornelia Roorda1, Cyriel Olie1, Muhammad Riaz1 &
Bogdan I. Florea2
1Department of Human Genetics, LUMC, Leiden, The Netherlands; 2Bio-organic Synthesis, Leiden Institute of Chemistry, Leiden, The Netherlands
Abstract
Background Protein homeostasis, primarily regulated by the ubiquitin–proteasome system is crucial for proper function of
cells. In tissues of post-mitotic cells, the impaired ubiquitin–proteasome system is found in a wide range of neuromuscular
disorders. Activity-based probes (ABPs) measure proteasomal proteolytic subunits and can be used to report protein
homeostasis. Despite the crucial role of the proteasome in neuromuscular pathologies, ABPs were not employed in muscle
cells and tissues, and measurement of proteasomal activity was carried out in vitro using low-throughput procedures.
Methods We screened six ABPs for specific application in muscle cell culture using high throughput call-based imaging
procedures. We then determined an in situ proteasomal activity in myofibers of muscle cryosections.
Results We demonstrate that LWA300, a pan-reactive proteasomal probe, is most suitable to report proteasomal activity in
muscle cells using cell-based bio-imaging. We found that proteasomal activity is two-fold and three-fold enhanced in fused
muscle cell culture compared with non-fused cells. Moreover, we found that proteasomal activity can discriminate between
muscles. Across muscles, a relative higher proteasomal activity was found in hybrid myofibers whereas fast-twitch myofibers
displayed lower activity.
Conclusions Our study demonstrates that proteasomal activity differ between muscles and between myofiber types. We
suggest that ABPs can be used to report disease progression and treatment efficacy.
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Introduction
Maintenance of protein homeostasis is essential for normal
cellular function. In post-mitotic cells, like muscles and
neurons, protein homeostasis is predominantly regulated by
autophagy and the ubiquitin–proteasome system, and in a
wide range on neuromuscular pathologies, the proteasomal
activity and/or autophagy are often impaired.1–3 Although
both cellular machineries are molecularly interconnected,
the proteasome is the prominent machinery of protein
degradation, in part because autophagy is cytoplasmic,
whereas the proteasome is nuclear and cytoplasmic.1,3
Impaired proteasomal activity fuels the accumulation of
misfolded proteins and formation of protein aggregates, a
pathological hallmark ofmany ageing-associated pathologies.4
Proteasomal activity could be an informative measure of
cellular pathology and response to drugs.
The constitutive 26S proteasome consists of a 20S catalytic
core, capped at each end by a 19S regulatory particle that
regulates the entry of proteins into the proteolytic cavity of
the 20S core.5 The 20S protein complex is composed of two
central β-subunits rings flanked at each end by a ring of α-
subunits. The catalytic core is a modular protein complex,
and proteolysis is executed by the β1, β2, and β5 subunits,
which possess caspase-like, trypsin-like, and chymotrypsin-
like specific activities, respectively.6 Libraries of specific
proteasomal inhibitors led to the development of activity-
based probes monitoring proteasomal activity (reviewed in
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Carmony and Kim,7 and Sieber8). The proteasome activity-
based probes (ABPs) are proteasomal inhibitors conjugated
to a fluorophore that irreversibly bind to the catalytic β-
subunits. ABPs can bind to the β1, β2, and β5 subunits
collectively or each subunit separately7,9 (Figure 1A). Those
ABPs specifically bind to the activated proteasomal subunits
allowing direct, accurate quantification of the proteasome.
Proteasomal activity can be measured using a number of
reliable assays measuring chymotrypsin-like, trypsin-like,
and caspase-like protease activities using fluorogenic
substrates.10 Their major shortcomings are as follows: low-
throughput, not cell-based, not subunit-specific, and not
suitable to report proteasomal activity in tissue sections.10
Impaired protein homeostasis is associated with
degenerated muscles and muscle pathologies.2,11 Decreased
proteasome activity in human muscles is age-associated,12
whereas in rats, proteasome activity in muscles increases
with age.13 We reported that proteasome activity is reduced
in a mouse model for muscle ageing.14 Despite the prominent
role of the proteasome in maintaining protein homeostasis in
muscles, the changes in proteasomal activity with age are not
fully understood. In most studies, measurements of
proteasomal activity in muscles and in muscle cell culture
are carried out predominantly by low-throughput
biochemical assays.12,15,16 Robust and accurate measurement
of proteasomal activity could report altered myogenesis and
muscle function. Here, we report the application of ABPs in
muscle cell culture and in muscle cryosections. We screened
six ABPs and demonstrate selective application of those ABPs
in high-throughput cell-based imaging procedures
(summarized in Figure 1B). Moreover, we show that the
binding efficacy of ABPs can differ between myofiber types
and discriminate between muscles. Our study demonstrates
that proteasomal activity probes can specifically monitor
proteasomal activity in skeletal muscles and open new
options to investigate altered protein homeostasis in
degenerated muscles and aged muscles.
Methods
Activity-based probes and inhibitors
Pan-reactive ABPs (LWA300, MV151, and MVB003) were
previously described.17–19 Subunit-specific ABPs LW124 and
MVB127, targeting β1 and β5 respectively, were described
in Verdoes et al.,20 and PR592 (β5) in Geurink et al.21
Inhibitors used in this study: Epox 1-0.5 μM (Sigma-Aldrich,
MO, USA); MG132 10 μM (Sigma-Aldrich, MO, USA); IU1
50 μM (AG Scientific). The subunit-specific inhibitors, NC-
001 (0.5 μM) and NC-005 (1-0.5 μM), were reported in
Britton et al.22
Cell culture
Immortalized mouse myoblasts, C2C12, were propagated as
described in de Klerk et al.23 Immortalized human myoblasts,
Figure 1 Screen of proteasome activity-based probes in muscle cell culture. (A) Six activity probes, divided into pan-reactive and subunit-specific, were
included in the study. Probes are classified between pan-reactive, which bind to all catalytic β-subunits, or subunit-specific (β1 or β5). The active subunits
β1, β2, and β5 are marked by yellow, blue, and red symbols, respectively. (B) The flow chart summarizes the screening procedure for the study in
muscles. All six probes were tested for binding specificity in muscle cell culture using activity gels. The probes demonstrated specific activities in muscle
cells were then assayed in living cells with cell-based imaging procedures. Only LWA300 demonstrated specific binding and was assayed in muscles.
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7304.1, were cultured according to Anvar et al.24 shUsp14
cell line was generated by transfection of shRNA clone
TRCN0000007428 (Sigma-Aldrich, MO, USA) into C2C12 using
Lipofectamin 2000 (Invitrogen) according to the
manufacturer manual. Scramble shRNA line was previously
described.14 Stable culture was generated by puromycin
selection. Cultures were propagated in a growth medium
with puromycin (2.5 μg/mL). Prior to LWA300 incubation,
puromycin was removed for 2–3 cell duelling.
Molecular analysis of the shUsp14 line was carried out
using RT-qPCR and Western blot analysis as described in de
Klerk et al.23 Usp14 was detected using the primer set, designed
by Primer 3 plus. The Usp14 protein was detected using the
GTX115186 polyclonal antibody (Gene Tex, Irvine, CA, USA).
The tubulin antibody was purchased from Sigma-Aldrich.
Activity-based probe analysis in activity gels
Activity-based probe binding to active proteasome subunits
in C2C12 was determined using activity gels. Specific binding
was determined by pre-incubation with Epox 1 μg/mL Epox
(Sigma-Aldrich, MO, USA); DMSO (1:1000; Mock) for 1 h at
37°C in a growth medium, following by an incubation with
the ABP (0.5 μM) for 1 h at 37°C in a growth medium. Pre-
incubation with other inhibitors was also carried out for 1 h
at 37°C in a growth medium. Subsequently, cells were
harvested by trypsinization, and cell pellets were stored in
80°C prior to analysis. Protein lysate was carried out in a
lysis buffer containing the following: 50 mM Tris-HCl [pH
7.5], 250 mM sucrose, 5 mM MgCl2, 1 mM DTT, 2 mM ATP,
0.025% digitonin, 0.2% NP40. Protein aliquots were resolved
by 12.5% SDS-PAGE as described in Florea et al.18 Wet gels
were visualized using BioRad ChemiDoc imaging systems
(BioRad, CA, USA; (λex = 530 nm, λem = 560 nm). Fluorescence
was normalized to a Coomassie Blue stained gel.
Cell-based activity-based probe activity
For cell-based analysis, ABP incubation was carried out as
described in the preceding section. The working
concentration was determined by serial dilutions and
clearance of the fluorescence by Epox pre-incubation.
Cultures were then washed with PBS (3×), 50 mM EDTA
(1×) and methanol:PBS (1:1) (1×), and counterstained with
Hoechst 33258 (Sigma Aldrich) (10 ng/mL). For imaging with
Leica DM5500 fluorescent microscope, cells were seeded on
glass, and after washing and dehydration cells were mounted
with Citifluor (Le, UK). Images were taken using LAS AF
software, version 2.3.6. High-throughput imaging was carried
out with ArrayScan VTI HCA, Cellomics (Thermo Scientific), in
cells seeds in a 96-well plate, images were taken directly after
washings. Image analysis was carried out with the Cellomics
(Thermofisher) compartmental bio-application as described
in Riaz et al.14 In brief, the nucleus was defined as a
reference, as detected by Hoechst staining. A 15 pixels ring
from the segmented nucleus was defined for each cell, and
LWA300 MFI was measured from both the nuclear part and
the ring was referred all the cell MFI; the nuclear MFI was
measured from the nuclear segmented circle. The same
protocol was used to measure LWA300 in all conditions.
Mean fluorescence is normalized to the area and to cultures
incubated with LWA300 only.
For analysis with the flow cytometry, labelled cells were
washed with PBS and were harvested by typsinization. Cells
were collected in ice-cold PBS and were maintained on ice
prior to analysis. ABP fluorescence was analysed using the
BD-LSR II flow cytometer. Events were gated on size using
the forward and side scatters (FSC and SSC; total 15 000
events), and subsequently, Hoechst positive events were
included for the ABP MFI measurements. Analysis of
fluorescence intensity was carried out with BD FACSDiva™
software version 8.0.1. MFI distribution curves were
generated using FlowJo software suite version 7.6.5 (FlowJo,
OR, USA). Background levels were determined by incubation
with the unconjugated fluorophores: Bodipy-FL (LWA300,
LW124, and PR592) and Bodipy-TMR (MV151, MVB003, and
MVB127) (Thermofisher).
Mice and histological staining and fibre typing of
muscle sections
Male, 5-week-old C57BL/6J mice (Jackson laboratories,
Sacramento, CA, USA) were acclimatized for 1 week and
standard conditions as detailed in Riaz et al.,25 under the
Animal Research: Reporting of In Vivo Experiments
guidelines. An animal research protocol [#13113] was
approved by the Institutional Animal Ethical Committee,
Leiden University Medical Center, Leiden, the Netherlands.
Muscles were harvested from 6-week-old mice. Cryosections
(10 μm) were made using the CM3050S cryostat (Leica
Microsystems). Muscle sections were pasted sequentially on
super frost plus glass slides (Menzel-Gläser; Thermo
scientific) and stored at 20 prior to staining. Prior to
incubation with inhibitors, tissue was equilibrated with
PBS/Tween 0.05%. Staining with LWA300 (0.05 μM) was
carried out in PBS for 40 min. Pre-incubation was carried
out with Epox 0.5 μM, NC-005 (0.5 μM), or DMSO (mock) in
PBS for 1 h. Subsequently, sections were washed with PBS
(3×), 50 mM EDTA (1×), and methanol:PBS (1:1) (1×),
dehydrated with ethanol and mounted in Citifluor (Le, UK).
All incubations were carried out at room temperature.
Myofiber typing was carried out in consecutive
cryosections using antibodies to three myosin heavy chain
isoforms conjugated as follows: type-2b with Alexa-488
(green), type-2a with Alexa-594 (red), and type-1 with
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Alexa-350 (blue).26 The immunofluorescence procedure was
carried out as detailed in Riaz et al.14,25 Images were
captured with the DM5500 microscope (Leica) using the LAS
AF software version 2.3.6. Image quantification in muscles
was carried out with ImageJ https://imagej.nih.gov/ij/.
Statistical analyses
Unless otherwise indicated, statistical analyses were
performed in Prism 7 (GraphPad software) and an unpaired
t-test. Density plots were made in R-studio with the ggplot2
package.
Results and Discussion
Screening of six ABPs was carried out in C2C12 immortalized
mouse myoblasts: three pan-reactive ABPs (LWA300,
MVB003, and MV151) and three subunit-specific probes
(Figure 1A). LWA300 and MVB003 contain the natural
compound Epoxomicin (Epox) core conjugated to BodipyFL
or Bodipy TMR fluorophore, respectively.18,27 MV151 is the
product of chemical design with an (Ahx)3 Leu3 core attached
at the C terminus to vinylsulphone electrophilic trap and at
the N terminus to BodipyTMR.17 LW124 contains a β1c/1i
selective sequence with epoxyketone electrophilic trap and
bodipy FL tag.27 PR592 and MVB127 are β5c/5i directed
probes with BodipyFL/epoxyketone and
BodipyTMR/vinylsulphone fluorophore/reactive group pair,
respectively.20,21 Specific binding to an active proteasome
was determined by pre-incubation with the proteasome
inhibitor, Epox. Epox competes with ABP binding to the active
proteasome subunits. ABP binding to active subunits was
determined using activity gels (Figure 2). All three pan-
reactive probes showed specific binding to the β2 and β5
subunits as Epox cleared the fluorescence signal (Figure 2A–
2C). MVB003 binding to β1 was not specific (Figure 2B).
Figure 2 Screening for specific activity-based probes binding in muscle cell culture using activity gels. (A–C) Pan-reactive probes. (D–F) Subunit-specific
activity-based probes. For each activity, probe representative gel images and Coomassie Blue stained gel are shown at the left side. A chart bar on the
right side shows the band intensity for each subunit after normalization to Coomassie Blue loading control. Averages and standard variation are from
three biological replicates. Grey bars show mock (DMSO pre-incubation followed by probe incubation) and black bars show pre-incubation with
Epoxomicin followed by incubation with the proteasome activity probe. Average and standard deviations are from three independent cultures,
statistical significance (p < 0.05; *) was assessed by the Student’s t-test.
Proteasomal activity-based probes mark protein homeostasis in muscles 801
Journal of Cachexia, Sarcopenia and Muscle 2017; 8: 798–807
DOI: 10.1002/jcsm.12211
Binding of MV151 was the least specific (Figure 2C), possibly
because it is a first-generation probe and is more
hydrophobic.17 Amongst the pan-reactive ABPs, LWA300
showed the most specific binding (Figure 2A). Of the
subunit-specific ABPs, binding of LW124 to the β1 subunit
and that of MVB127 to the β5 subunit was found to be
specific in C2C12 myoblasts (Figure 2D–2E). However, PR592
displayed no decrease in fluorescence following pre-
incubation in Epox, indicating lack of specificity (Figure 2F).
With all three pan-reactive probes, the signal from β5 was
higher compared with β1 and β2 in the muscle cell culture
(Figure 2A–2C).
Specific binding in C2C12 cell culture was further assessed
by pre-incubation with the MG132, and reduced LWA300
signal fluorescence was found for β5, β1, and β2 subunits
(Figure 3A). However, MG132 competition with LWA300
binding to β5 and β2 was less effective compared with Epox.
This observation is in agreement with recent studies showing
that MG132 inhibition of proteasome activity is less specific
than Epox.28 In addition, pre-incubation with NC-005, an
inhibitor of β5 subunit, led to a reduction in the β5 signal
whilst fluorescence in β2 and β1 is unaffected (Figure 3B).
To assess whether altered proteasome activity, we
generated stable Usp14-knockdown in C2C12 using shRNA
to Usp14 (Figure 3C and 3D). Compared with scramble
(scram) cell culture, β5 and β1 signals in shUsp14 were
significantly increased, whereas β2 signal less unaffected
(Figure 3E). Moreover, β5 and β1 signals were also elevated
in scram cell culture after pre-incubation with IU1, an
Usp14 inhibitor (Figure 3E). Inhibition of Usp14 elevates
proteasome activity in mouse fibroblasts cell culture.29
Our study suggests that Usp14 predominantly affects β5
activity in C2C12 cell culture.
The pattern of signal from the β-subunits in C2C12 cells
differ from that reported in HeLa cells. In HeLa cells, all three
β-subunits show similar signal intensity,17 but in the muscle
cell culture, we found that the β5 signal is two-fold to four-
fold higher than β2 and β1, respectively. We recently
Figure 3 Verification of LWA300 specific activity in C2C12 cell culture. (A) MG132 (10 mM) pre-incubation competes with LWA300 binding to β-
subunits. The image shows a representative activity gel, and the bar chart shows signal quantification. (B) NC-005 (1 μM) pre-incubation competes
with LWA300 binding to the β5-subunit. The image shows a representative activity gel, and the bar chart shows signal quantification. (C–D) Usp14
stable KD in C2C12. (C) Usp14 levels were measured using RT-qPCR; fold change was calculated after normalization to Hprt and scramble control.
Average and standard deviation are from three biological replicates. (D) Western blot shows Ups14 protein levels. Tubulin shows equal loading. (E)
LWA300 binding to β-subunits in shUps14 and IU1-treated scramble cells. The image shows a representative activity gel and the corresponding
Coomassie Blue staining and bar chart shows signal quantification. For all activity gels, the band intensity for each subunit is normalized to Coomassie
Blue loading control. Averages and standard variation are from three biological replicates. Statistical significance (p < 0.05; *) was assessed by the
Student’s t-test.
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reported that in the C2C12 cell culture, β5 protein levels are
lower than β2;14 this indicates that β5 activity in C2C12 is
higher than β2 activity. Also, in mouse thymus, the β5 signal
is higher compared with the other subunits.18 Thus, specific
proteasomal activity in cells and tissues should include
subunit-specific analysis.
The probes with most specific binding (LWA300, LW124,
and MVB127) were then applied in cell-based imaging assays.
For high-throughput imaging, we tested specificity in cells
using flow cytometry. Signal specificity was determined by
pre-incubation with Epox, and Hoechst was used to gate
the living cells (Figure 4A). A concentration curve reveals
differences in signal specificity between the ABPs
(Figure 4B). The LWA300 signal was found to be the most
specific as fluorescence was abolished by Epox pre-incubation
(Figure 4B). LW124 and MVB127 staining was found to be
less or not specific, respectively (Figure 4B). Imaging of the
ABPs signal in adherent C2C12 cells confirmed that the
MVB127 signal in cells was not reduced in Epox-treated cells
(Figure 4C). The MVB127 non-specific signal was mostly
localized to membrane structures because of its lipophilic
property.18 The LW124 non-specific signal was found in the
nucleus (Figure 4C). LWA300 fluorescence was found in both
nuclear and cytoplasmic compartments, and Epox pre-
incubation abolished the fluorescence signal from both
compartments (Figure 4C). Together, those experiments
indicate that ABPs are suitable to monitor proteasome
activity in intact cells using flow cytometry.
Flow cytometry in muscle cell culture possesses a number
of shortcomings, as differentiated multinucleated muscle
cells are too large for the conventional flow cytometry. We
then assessed LWA300 fluorescence in adherent and fused
C2C12 cell cultures using the Cellomics imaging system. In
previous studies, we demonstrated that this imaging system
Figure 4 Cell-based quantification of proteasomal activity in C2C12 immortalized murine cell culture. (A–B) Analysis of activity-based probes specific
binding in living C2C12 cells using flow cytometry. (A) Distribution plots show LWA300 (green) and Hoechst (blue) mean fluorescence intensity in mock
(LWA300) and Epoxomicin-treated cell cultures. (B) Plots show a concentration curve of the average mean fluorescence intensity for LWA300, LW124,
or MVB127 in mock or Epoxomicin-treated cell cultures. Average mean fluorescence intensity was calculated from ~10 000 cells per treatment.
Averages and standard variations are from three replicates. (C) Images show activity-based probe fluorescence distribution within C2C12 cells:
LWA300 (green), LW124 (green), or MVB127 (red) in mock or pre-incubation with Epoxomicin. The cell nucleus is stained with DAPI. In the upper right
box in each image, a single nucleus without a DAPI overlap is shown, and the same nucleus is marked with a yellow ring in the overlay image. Scale bar
7.5 μm. (D) Images of LWA300 signal in C2C12 cells. The right panel shows cells after pre-incubation with Epoxomicin. Colour images show overlay
between LWA300 and Hoechst. A grey-scale image of LWA300 signal is shown in the upper right box, and nuclear segmentation by the Cellomics
software is depicted with a circle. (E) Bar chart shows LWA300 mean fluorescence intensity measurements in flow cytometry and Cellomics, in mock
or pre-treatment with Epoxomicin, NC-005 or NC-001. Measurements in Cellomics were carried out for the nuclear (N) fraction or the
preinuclear + nuclear regions (P + N). Means and standard deviations are depicted. Measurements were normalized to mock-treated cells. Averages
and standard deviations are from three biological replicates; in each condition, flow cytometry averages are from ~10 000 cells, and Cellomics averages
are from ~3000 cells.
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is highly suitable for high-throughput of fused muscle cell
cultures.24,30 In agreement with the flow cytometry
experiments, also with the Cellomics, we measured the
reduced LWA300 signal by Epox pre-incubation
(Figure 4D–4E). Using the Cellomics tools, we assessed the
LWA300 signal in the nucleus, and found an enrichment of
nuclear signal in C2C12 cells (Figure 3E). We then also
investigated subunit-specific activity in the C2C12 muscle cell
culture using pre-incubation with the NC-005 or NC-001 β5 or
β1 specific inhibitors, respectively. Consistently, NC-005 was
found to be more effective compared with NC-001
(Figure 4E). This suggests that β5 is more active in C2C12 cells
moreover in the cell nucleus. This conclusion is also
consistent with the higher β5 activity that was observed by
activity gels.
The immortalized human muscle cells (7304.1) exhibit a
high fusion index and are more suitable for analyses of
fused cells as compared with C2C12 cells.30 We compared
proteasomal activity in fused cultures and found a higher
LWA300 signal in fused human muscle cells compared with
non-fused cultures (Figure 5A). Confirming the results in
the mouse C2C12 myoblasts, LWA300 binding was
competed with Epox or NC-005 pre-treatment, whereas
pre-treatment with NC-001 had little effect on the LWA300
signal (Figure 5B). In fused cells, the LWA300 average signal
in the cell nucleus was nearly three-fold higher compared
with non-fused cultures, and the average signal in the
perinuclear cytoplasmic region was 1.5-fold higher
(Figure 5C). This indicates that proteasomal activity in
muscle cells varied between cell compartments and changes
within cell compartments could alter during cell fusion.
Enrichment of proteasomal subunits in the nuclear fraction
was previously reported in rat liver and several non-muscle
cells.31 Dynamic sub-cellular distribution of proteasomal
subunits was found in cancer cell cultures, and components
of the 19S were enriched in the nuclear fraction.32 The
change in proteasomal activity during cell fusion could also
be due to the increase in expression of specific subunits.
Nevertheless, these results reveal that proteasomal activity
increases in fused cultures.
Figure 5 Cell-based quantification of proteasomal activity in 7304.1 immortalized human myoblasts. (A) Representative images of the LWA300 signal
in non-fused or fused cell cultures. The colour image shows the overlay between LWA300 and Hoechst. The grey-scale images show LWA300 signal.
The nuclear region is within the cyan circle, and the peri-nuclear region is situated between the nuclear circle and the yellow ring. The scale bar is
20 μm. (B) The bar chart shows LWA300 mean fluorescence intensity normalized to mock-treated in Epoxomicin, NC-001, and NC-005 treated cell
cultures. Averages and standard deviations are from three replicates. (C) The bar chart shows LWA300 mean fluorescence intensity in non-fused
and fused 7304.1 cell cultures in the nuclear and perinuclear regions. Shown are mean fluorescence intensity and standard error. Significant difference
(p < 0.05) between mock and treatment was assessed by the student’s t-test and is denoted with *.
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We then examined LWA300-specific binding in mouse
quadriceps muscle cryosections. The LWA300 signal in
myofibers was abolished by pre-incubation with Epox or NC-
005, and tissue auto-fluorescence was not detectable by the
imaging conditions that were used to image the LWA300
signal (Figure 6Aa–d). At a higher magnification, the LWA300
signal form puncta were visible in both cross sections and
longitudinal sections (Figure 6Ae–f). Those puncta could
represent active proteasomes in the endoplasmatic reticulum,
as the proteasome is enriched in the endoplasmatic reticulum
in muscles.33 As expected, the LWA300 signal was also found
within myonuclei, as determined by the overlap with DAPI
staining (Figure 6Ae). Most striking, the LWA300 signal varied
between myofibers (Figure 6Ab).
To assess whether proteasome activity differs between
muscles, LWA300 staining was performed in two fast-twitch
muscles (quadriceps and gastrocnemius), and in soleus and
slow-twitch muscle (Figure 6B). Mean fluorescence intensity
(MFI) was measured within each myofiber, and differences
in MFI were assessed using density plots (Figure 6C),
revealing a distinguished pattern for each muscle. Most
noticeable, the fast-twitch muscles showed higher LWA300
fluorescence compared with the slow-twitch muscle
(Figure 6C). In addition, the MFI distribution was narrow in
Figure 6 Proteasomal activity in myofibers of mouse muscles. (A) LWA300 binding specificity in quadriceps muscle cryosections. (a) A negative control
shows auto fluorescence. (b–f) incubation with LWA300 (b, e–f) or pre-incubated with Epox (c) or NC-005 (d). The scale bars are 50 um (a–d), 10 um
(e), 25 um (f). (a–e) show cross-sections and (f) shows longitudinal section. (e) In the upper box, LWA300 co-localization with DAPI is shown. (B)
LWA300 staining (upper row) in myofiber types (lower row) in quadriceps, soleus and gastrocnemius muscles. Myofiber typing was carried out using
immunohistochemistry to MyHC-2b (green), MyHC-2a (red), or MyHC-1 (blue). Examples of corresponding myofibers between the sequential images
are designated with numbers. The scale bar is 50 μm. (C) Density plots show LWA300 mean fluorescence intensity distribution across myofibers. Per
muscle, over 150 myofibers are included. (D) Distribution plots show per myofibers mean fluorescence intensity of LWA300 and the three myosin
heavy chain isotypes in each muscle. LWA300 mean fluorescence intensity sorts myofibers. Myofiber type profile is depicted. Hybrid myofiber indicates
the expression of at least two mean fluorescence intensity isotypes.
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soleus—suggesting homogeneous staining across myofiber
types, whereas in quadriceps and gastrocnemius, MFI
distribution was broad, suggesting heterogeneity in
proteasomal activity between myofibers. We then
investigated whether LWA300 correlates with a myofiber
type. A muscle is composed of different myofibers that can
be distinguished by the expression of myosin heavy chain
(MyHC) isotypes.34 We assessed whether LWA300 intensity
is associated with myofiber type in sequential cryosections
that were stained for LWA300 or with a mix of conjugated
antibodies to MyHC type-2b, type-2a, and type-1.
Fluorescence intensity of LWA300 and MyHC isotypes was
quantified per myofiber, and an association between
LWA300 MFI and myofiber type was assessed in three
muscles. In quadriceps, higher LWA300 MFI was
predominantly found in hybrids expressing MyHC-2b and -2a,
(Figure 6D; Quadriceps), whereas myofibers with a dominant
MyHC-2b had a lower LWA300 signal (Figure 5D; Quadriceps).
In soleus muscle, MyHC-2a and MyHC-1 are predominantly
expressed whilst MyHC-2b is scarce. A higher LWA300 signal
was found in hybrid myofibers expressing MyHC-1 and 2a
(Figure 6D; Soleus). In myofibers with a dominant MyHC-1
staining, LWA300 signal was lower (Figure 6D; Soleus).
Thus, the higher LWA300 signal was found in hybrid
myofibers in both quadriceps and soleus. We then also
investigated the LWA300 signal within myofibers in the
gastrocnemius muscle, in which all three MyHC isotypes
are co-expressed.35 Overall, LWA300 was higher in
gastrocnemius compared with soleus or quadriceps, and
most myofibers expressed at least two MyHC isotypes. A
lower LWA300 signal was found in myofibers expressing
MyHC-2b (Figure 6D; Gastrocnemius), whereas a higher
LWA300 signal was found in hybrid myofibers expressing
MyHC-1 and -2a, or 2b-2a (Figure 5D; Gastrocnemius).
Higher proteasomal activity in hybrid myofibers,
irrespective of oxidative or glycolytic state, suggests that
hybrid fibres require a higher protein turnover. The
biological impact of hybrid myofibers could represent a
transition phase between oxidative or glycolytic state.14
The biological impact of hybrid myofibers is not fully
understood, and an increase in hybrid myofibers was found
during muscle repair.36 Together, our study reveals that
proteasomal activity differ between myofibers and between
muscles.
Skeletal muscle function in the mammalian body is highly
diverse with respect to fatigue resistance and response time
of the twitch, reflected by a dynamic pattern of histochemical
properties.26 Our studies revealed a muscle-specific pattern of
LWA300 staining. The heterogeneity of myofiber types, as
determined by MyHC isotype expression, reflects primarily
an adaptation to the different temporal and spatial activities
of skeletal muscles.26 Here, we show that proteasomal activity
differ between myofibers, suggesting that proteasomal
activity contributes to changes in myofiber function and
adaptation to prevailing conditions. Protein homeostasis and
the ubiquitin proteasome system play a central role in muscle
atrophy.37,38 In a recent study, we found that the LWA300
signal is reduced within myofibers of the tibialis anterior
muscle in a model for muscle ageing; specifically, the reduced
LWA300 signal was found in atrophic myofibers.14 This
suggests that measuring proteasomal activity in muscles in
different conditions could contribute to understand the
pattern of myofiber function in different muscles.
In conclusion, this study demonstrated that the pan-
reactive LWA300 is the most consistently specific probe for
the detection of proteasomal activity in muscle cells and
tissue. We show that proteasomal activity differs between
myofibers, and under normal conditions, a higher
proteasomal activity was found in hybrid myofiber expressing
MyHC-2a, whereas myofibers that predominantly express
one MyHC isotype showed a low LWA300 signal. As
proteasomal activity plays a central role in neuromuscular
disorders and aged muscles, and the ubiquitin–proteasome
system plays a prominent role in muscle protein homeostasis,
we suggest that measuring proteasomal activity could be
valuable to understand changes in muscle pathology. The
application of ABPs in cancer cells demonstrated to
accurately measure protein homeostasis and its restoration
response to drugs.39,40 Future studies could explore the
application of ABPs to monitor progression in muscle
pathology and treatment efficacy in muscular dystrophies.
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